Supplementary materials: Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver

<b>These are peer-reviewed supplementary materials for the article '</b><b>Impact of perioperative chemotherapy on </b><b>survival outcomes among patients with </b><b>metastatic colorectal cancer to the liver</b><b>' published in the</b><b> </b><b><i>Journal of Comparative Effectiveness Research</i></b><b>.</b><b>Supplementary figure A: </b>Median overall survival in the whole cohort according to the treatment modality after propensity score matching.<b>Supplementary figure B: </b>Overall survival according to the treatment modality after excluding patients with 90-day mortality of most definitive primary site surgery after propensity score matching.<b>Supplementary figure C: </b>Median overall survival comparison between single agent and multiagent chemotherapy after propensity score matching.<b>Supplementary figure D: </b>Median overall survival comparison between adjuvant and neoadjuvant chemotherapy after propensity score matching.<b>Supplementary figure E: </b>Median overall survival according to the treatment modality in (A) MSI-H and (B) MSI-L.<b>Supplementary figure F: </b>Median overall survival comparison between single agent and multiagent chemotherapy in (A) MSI-H and (B) MSI-L.<b>Supplementary figure G:</b> Median overall survival comparison between adjuvant and neoadjuvant chemotherapy in (A) MSI-H and (B) MSI-L.<b>Supplementary Table A: </b>Baseline characteristics of metastatic CRC patients with liver metastases according to the treatment modality after propensity score matching.<b>Supplementary Table B:</b> Baseline characteristics of metastatic CRC patients with liver metastases excluding patients with 90-day mortality of most definitive primary site surgery according to the treatment modality after propensity score matching.